AbbVie to buy Pharmacyclics for pipeline boost
Tuesday, March 10, 2015 - 12:00
in Mathematics & Economics
$21bn deal gives AbbVie a share in sales of blockbuster cancer drug as its own biggest sellers face patent expiry
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via